Enliven Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q1 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Enliven Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q1 2020 to Q1 2022.
  • Enliven Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending March 31, 2022 was $647K, a 183% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $647K +$418K +183% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $229K -$55K -19.4% Dec 31, 2021 10-K 2022-03-15
Q3 2021 $229K -$55K -19.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $229K -$49K -17.6% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $229K -$49K -17.6% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $284K Dec 31, 2020 10-K 2021-03-05
Q3 2020 $284K Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $278K Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $278K Mar 31, 2020 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.